EffRx Pharmaceuticals is attending 24th Edition of the WCO-IOF-ESCEO – World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – which takes place in London on April 11-14, 2024. EffRx will have a booth featuring Binosto® (buffered soluble alendronate 70mg), the first and only buffered solution for the treatment of osteoporosis.
The IOF Congress is one of the most significant events in the field of osteoporosis and bone health, bringing together renowned scientists, healthcare professionals, and industry experts from around the world.
